SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-421528"
 

Sökning: id:"swepub:oai:DiVA.org:uu-421528" > The impact of local...

The impact of local control in the treatment of children with advanced infantile and adult-type fibrosarcoma : Experience of the cooperative weichteilsarkom studiengruppe (CWS)

Sparber-Sauer, Monika (författare)
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
Vokuhl, Christian (författare)
Kiel Pediat Tumor Registry, Sect Pediat Pathol, Dept Pathol, Kiel, Germany.
Seitz, Guido (författare)
Univ Childrens Hosp Marburg, Dept Pediat Surg, Marburg, Germany.
visa fler...
Stegmaier, Sabine (författare)
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
Hallmen, Erika (författare)
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
von Kalle, Thekla (författare)
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Olgahosp,Inst Radiol, Stuttgart, Germany.
Scheer, Monika (författare)
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
Muenter, Marc (författare)
Klinikum Stuttgart, Inst Radiotherapy, Stuttgart, Germany.
Bielack, Stefan S. (författare)
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.;Univ Munster, Dept Pediat Hematol & Oncol, Munster, Germany.
Ladenstein, Ruth (författare)
St Anna Childrens Hosp, Pediat Oncol, Vienna, Austria.
Niggli, Felix (författare)
Univ Zurich, Dept Pediat Oncol, Zurich, Switzerland.
Ljungman, Gustaf, 1958- (författare)
Uppsala universitet,Institutionen för kvinnors och barns hälsa
Fuchs, Joerg (författare)
Univ Childrens Hosp, Dept Pediat Surg & Urol, Tubingen, Germany.
Klingebiel, Thomas (författare)
Goethe Univ, Univ Frankfurt, Dept Children & Adolescents, Frankfurt, Germany.
Koscielniak, Ewa (författare)
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.;Goethe Univ, Univ Frankfurt, Dept Children & Adolescents, Frankfurt, Germany.
visa färre...
Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany Kiel Pediat Tumor Registry, Sect Pediat Pathol, Dept Pathol, Kiel, Germany. (creator_code:org_t)
W B SAUNDERS CO-ELSEVIER INC, 2020
2020
Engelska.
Ingår i: Journal of Pediatric Surgery. - : W B SAUNDERS CO-ELSEVIER INC. - 0022-3468 .- 1531-5037. ; 55:9, s. 1740-1747
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background and objectives: This study aims at examining the potential survival benefits of primary versus secondary surgery of children diagnosed with advanced infantile (iFS) and adult-type fibrosarcoma (aFS). Methods: Treatment and outcome of 89 children with FS treated within prospective Cooperative Studiengruppe (CWS) trials (1981-2016) were analyzed retrospectively. Results: Localized disease (LD) was diagnosed in 87 patients: 64/66 patients with iFS (<= 2 years) and 23 with aFS (>2 <= 18 years). Two patients (iFS) had metastatic disease. Resection was the mainstay of therapy of patients with LD resulting in microscopically complete (R0, IRS group I) (n = 29/87, 33%), microscopically incomplete (R1, IRS group II) (n = 17/87, 20%) and macroscopically incomplete (R2, IRS group III) (n = 41/87, 47%). Advanced LD (IRS group Ill) was present in 32/64 (50%) palieras with iFS and in 9/23 (39%) with aFS. Chemotherapy was added predominantly in patients with advanced disease and an assessable objective response to CHT was seen in 71% iFS and 75% aFS. The 5 -year event-free survival (EFS) of patients with iFS and aFS was 81% (+/- 10, 95% Cl) and 70% (+/- 19, 95% Cl) (p = 0.24); the 5 -year overall survival (OS) was 98% (+/- 3, 95% Cl) and 82% (+/- 16, 95% Cl) (p = 0.02). Primary resection was no prognostic factor. Secondary R0/R1 resection in patients with advanced disease improved 5-year EFS and OS in aFS (p = 0.002 and p = 0.000) but not in infants. Conclusions: Secondary resection improves outcome in advanced aFS but not in infants. Mutilating surgery in infants should be avoided. (C) 2019 Elsevier Inc. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

Nyckelord

Fibrosarcoma
Infantile
Adult-type
CWS group

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy